S. Kumar et al. / Journal of Organometallic Chemistry 694 (2009) 4162–4169
4167
these
r
-interactions in these palladium complexes were found to
116.8 (NCHCHN), 53.9 (CH2), 53.9 (CH(CH3)2), 42.9 (CH2), 23.6
(CH(CH3)2). IR (KBr pellet cmꢀ1): 1676 (
CO). Anal. Calc. for
be low lying and consequently are less susceptible to nucleophilic
or electrophilic attacks.
m
C30H38ClAgN6O2ꢂ0.5CH2Cl2: C, 52.30; H, 5.61; N, 12.00. Found: C,
52.60; H, 6.36; N, 11.99%.
4. Experimental
4.4. Synthesis of [1-(i-propyl)-3-{N-(benzylacetamido)imidazol-2-
ylidene]2PdCl2 (1c)
4.1. General procedures
A mixture of {[1-(i-propyl)-3-{N-(benzylacetamido)imidazol-2-
ylidene}]2Ag}+Clꢀ (0.304 g, 0.462 mmol) and (COD)PdCl2 (0.132 g,
0.462 mmol) was dissolved in CH2Cl2 (ca. 40 mL) and was stirred
at room temperature for 6 h, at which the point the formation of
an off-white AgCl precipitate was observed. The reaction mixture
was filtered, and the solvent was removed under vacuum to get
the crude product. The crude product was purified by column chro-
matography on silica gel, using a CHCl3/CH3OH mixture (50:1) as
an eluent to obtain the product 1c as a yellow solid (0.167 g,
52%). 1H NMR (CDCl3, 400 MHz, 25 °C): d 7.50 (s, 1H, NCHCHN),
7.42 (s, 1H, NCHCHN), 7.24–7.21 (m, 9H, C6H5), 7.04 (d, 1H,
3JHH = 8 Hz, o-C6H5), 6.98 (s, 2H, NCHCHN), 6.97 (br, 2H, NH), 5.59
All manipulations were carried out using a combination of a
glovebox and standard Schlenk techniques. Solvents were purified
and degassed by standard procedures. 1-i-propylimidazole [32], 1-
benzylimidazole [33] and (COD)PdCl2 [34] were prepared accord-
ing to the reported literature procedures. 1H and 13C {1H} NMR
spectra were recorded on a Varian 400 MHz NMR spectrometer.
1H NMR peaks are labeled as singlet (s), doublet (d), triplet (t),
and septet (sept). Infrared spectra were recorded on a Perkin–El-
mer Spectrum One FT-IR spectrometer. Mass spectrometry mea-
surements were done on
a Micromass Q-Tof spectrometer.
Elemental Analysis was carried out on Thermo Quest FLASH 1112
SERIES (CHNS) Elemental Analyzer. X-ray diffraction data for com-
pounds 1c and 2c were collected on an Oxford Diffraction Excalib-
er-S diffractometer and crystal data collection and refinement
parameters are summarized in Table S1. The structures were
solved using direct methods and standard difference map tech-
niques, and were refined by full-matrix least-squares procedures
on F2 with SHELXTL (Version 6.10) [35,36]. GC spectra were obtained
on a Perkin–Elmer Clarus 600 equipped with a FID. GCMS spectra
were obtained on a Perkin–Elmer Clarus 600 T equipped with an
EI source.
3
3
(sept, 1H, JHH = 7 Hz, CH(CH3)2), 5.50 (sept, 1H, JHH = 7 Hz,
CH(CH3)2), 5.25 (s, 2H, CH2), 5.07 (s, 2H, CH2), 4.41 (d, 2H,
3
3JHH = 6 Hz, CH2), 4.39 (d, 2H, JHH = 6 Hz, CH2), 1.61 (d, 6H,
3
3JHH = 7 Hz, CH(CH3)2), 1.51 (d, 6H, JHH = 7 Hz, CH(CH3)2). 13C{1H}
NMR (CDCl3, 100 MHz, 25 °C): d 169.3 (Pd–NCN), 169.2 (Pd–
NCN), 167.1 (CO), 167.0 (CO), 138.2 (ipso-C6H5), 138.1 (ipso-C6H5),
128.5 (m-C6H5), 128.4 (m-C6H5), 127.8 (o-C6H5), 127.7 (o-C6H5),
127.2 (p-C6H5), 127.2 (p-C6H5), 121.9 (NCHCHN), 121.7 (NCHCHN),
118.1 (NCHCHN), 117.6 (NCHCHN), 54.4 (CH2), 54.0 (CH2), 52.8
(CH(CH3)2), 52.5 (CH(CH3)2), 43.5 (CH2), 43.4 (CH2), 23.3
(CH(CH3)2), 23.2 (CH(CH3)2). IR (KBr pellet cmꢀ1): 1683 (
mCO). Anal.
4.2. Synthesis of 1-(i-propyl)-3-N-(benzylacetamido)imidazolium
chloride (1a)
Calc. for C30H38PdCl2N6O2ꢂCH2Cl2: C, 47.92; H, 5.19; N, 10.82.
Found: C, 47.91; H, 5.87; N, 11.28%.
A mixture of N-benzyl-2-chloro-acetamide (3.20 g, 17.5 mmol)
and 1-i-propylimidazole (2.51 g, 22.7 mmol) was dissolved in tolu-
ene (ca. 10 mL), and refluxed at 110 °C for 12 h, at which point a so-
lid separated out. The solid was isolated by decanting off the
solvent and washed with hot hexane (3 ꢁ ca. 15 mL) to obtain
the product 1a as an off-white solid (4.31 g, 84%). 1H NMR (CDCl3,
400 MHz, 25 °C): d 10.05 (s, 1H, NCHN), 9.73 (s, 1H, NH), 7.57 (br,
4.5. Synthesis of 1-(benzyl)-3-N-(benzylacetamido)imidazolium
chloride (2a)
A mixture of N-benzyl-2-chloro-acetamide (3.15 g, 17.2 mmol)
and 1-benzylimidazole (2.72 g, 17.2 mmol) was dissolved in tolu-
ene (ca. 10 mL), and refluxed at 110 °C for 12 h, at which point a so-
lid separated out. The solid was isolated by decanting off the
solvent and washed with hot hexane (3 ꢁ ca. 15 mL) to obtain
the product 2a as an off-white solid (4.75 g, 81%). 1H NMR (CDCl3,
400 MHz, 25 °C): d 9.97 (s, 1H, NCHN), 9.73 (br, 1H, NH), 7.50 (s,
1H, NCHCHN), 7.36 (br, 2H, o-C6H5), 7.34 (br, 1H, o-C6H5), 7.31
3
1H, NCHCHN), 7.34 (d, 2H, JHH = 8 Hz, o-C6H5), 7.26 (t, 2H,
3JHH = 8 Hz, m-C6H5), 7.21 (m, 2H, p-C6H5 & NCHCHN), 5.37 (s, 2H,
CH2), 4.65 (sept, 1H, 3JHH = 7 Hz, CH(CH3)2), 4.40 (d, 2H, 3JHH = 6 Hz,
3
CH2), 1.58 (d, 6H, JHH = 7 Hz, CH(CH3)2). 13C{1H} NMR (CDCl3,
3
100 MHz, 25 °C): d 165.2 (CO), 138.0 (ipso-C6H5), 135.5 (NCHN),
128.3 (m-C6H5), 127.4 (o-C6H5), 126.9 (p-C6H5), 123.8 (NCHCHN),
119.4 (NCHCHN), 52.9 (CH2), 51.2 (CH(CH3)2), 43.1 (CH2), 22.6
(br, 1H, o-C6H5), 7.29 (br, 1H, m-C6H5), 7.20 (t, 3H, JHH = 7 Hz, m-
3
C6H5), 7.13 (d, 2H, JHH = 7 Hz, p-C6H5), 7.05 (s, 1H, NCHCHN),
3
5.36 (s, 2H, CH2), 5.32 (s, 2H, CH2), 4.36 (d, 2H, JHH = 6 Hz, CH2).
(CH(CH3)2). IR (KBr pellet cmꢀ1): 1684 (
258.1614 [(NHCꢀH)]+, calcd 258.1606.
mCO). HRMS (ES): m/z
13C{1H} NMR (CDCl3, 100 MHz, 25 °C): d 164.9 (CO), 138.2 (ipso-
C6H5), 137.6 (ipso-C6H5), 132.6 (NCHN), 129.8 (m-C6H5), 129.7
(m-C6H5), 128.8 (o-C6H5), 128.6 (o-C6H5), 127.9 (p-C6H5), 127.3
(p-C6H5), 124.0 (NCHCHN), 120.9 (NCHCHN), 53.6 (CH2), 51.8
4.3. Synthesis of {[1-(i-propyl)-3-N-(benzylacetamido)imidazol-2-
ylidene]2Ag}+Clꢀ (1b)
(CH2), 43.6 (CH2). IR (KBr pellet cmꢀ1): 1689 (
z 306.1620 [(NHCꢀH)]+, calcd 306.1606.
mCO). HRMS (ES): m/
A mixture of 1-(i-propyl)-3-N-(benzylacetamido)imidazolium
chloride (4.37 g, 14.9 mmol) and Ag2O (1.72 g, 7.45 mmol) in
dichloromethane (ca. 40 mL) was stirred at room temperature for
4 h. The reaction mixture was filtered, and the solvent was re-
moved under vacuum to give the product 1b as a white solid
(3.28 g, 67%). 1H NMR (CDCl3, 400 MHz, 25 °C): d 9.12 (br, 2H,
4.6. Synthesis of {[1-(benzyl)-3-N-(benzylacetamido)imidazol-2-
ylidene]2Ag}+Clꢀ (2b)
A
mixture of 1-(benzyl)-3-N-(benzylacetamido)imidazolium
chloride (4.37 g, 12.8 mmol) and Ag2O (1.48 g, 6.41 mmol) in
dichloromethane (ca. 40 mL) was stirred at room temperature for
4 h. The reaction mixture was filtered, and the solvent was re-
moved under vacuum to give the product 2b as a white solid
(2.89 g, 61%). 1H NMR (CDCl3, 400 MHz, 25 °C): d 9.36 (br, 2H,
NH), 7.30 (br, 2H, NCHCHN), 7.28 (br, 4H, o-C6H5), 7.27–7.25 (br,
4H, m-C6H5), 7.17 (br, 2H, o-C6H5), 7.15 (br, 4H, m-C6H5), 7.07–
3
NH), 7.31 (t, 4H, JHH = 3 Hz, m-C6H5), 7.28 (br, 4H, o-C6H5), 7.19
(br, 2H, p-C6H5), 7.17 (br, 2H, NCHCHN), 7.02 (br, 2H, NCHCHN),
3
5.00 (s, 4H, CH2), 4.64 (sept, 2H, JHH = 7 Hz, CH(CH3)2), 4.38 (s,
4H, CH2), 1.48 (d, 12H, 3JHH = 7 Hz, CH(CH3)2). 13C{1H} NMR (CDCl3,
100 MHz, 25 °C): d 179.8 (Ag–NCN), 166.8 (CO), 138.1 (ipso-C6H5),
128.2 (m-C6H5), 127.5 (o-C6H5), 126.8 (p-C6H5), 123.0 (NCHCHN),